The Biology of Hypomorphic TP53 Variants and Implications for Clinical Management.
- DOI
- 10.1158/1078-0432.ccr-25-4543
- Published
- 2026 Aug 14
- Container
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-25-4543,
title = {The Biology of Hypomorphic TP53 Variants and Implications for Clinical Management.},
author = {Moses R and Powers J and Levine AS and Garber JE and MacFarland SP and Rana HQ and Murphy ME and Maxwell KN},
year = {2026},
journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
doi = {10.1158/1078-0432.ccr-25-4543},
url = {https://doi.org/10.1158/1078-0432.ccr-25-4543}
}RIS
TY - JOUR TI - The Biology of Hypomorphic TP53 Variants and Implications for Clinical Management. AU - Moses R AU - Powers J AU - Levine AS AU - Garber JE AU - MacFarland SP AU - Rana HQ AU - Murphy ME AU - Maxwell KN PY - 2026 JO - Clinical cancer research : an official journal of the American Association for Cancer Research DO - 10.1158/1078-0432.ccr-25-4543 UR - https://doi.org/10.1158/1078-0432.ccr-25-4543 ER -
APA
R, M., J, P., AS, L., JE, G., SP, M., HQ, R., ME, M., & KN, M. (2026). The Biology of Hypomorphic TP53 Variants and Implications for Clinical Management.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-4543
Source records
- pubmed · retrieved 2026-09-27T06:24:28.322Z